Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Link to 8k

Alliacense has attempted to negotiate an MMP license with HTC without success. It provided litigation support in connection with the HTC trial in Fall 2013. The parties are presently in a negotiation to settle the HTC lawsuit and potentially issue an MMP license, or license with respect to some MMP patents, to HTC.

Share
New Message
Please login to post a reply